CD274 and colitis: Suppression of PD-L1 with anti-PD-L1 monoclonal antibodies (mAbs) reduced chronic intestinal inflammation in the T cell transfer murine model of colitis (21), whereas use of a PD-L1Fc was shown to protect against T cell transfer-colitis (22).